691 related articles for article (PubMed ID: 30351346)
21. Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI.
Ezzati A; Zammit AR; Habeck C; Hall CB; Lipton RB;
Brain Imaging Behav; 2020 Oct; 14(5):1792-1804. PubMed ID: 31104279
[TBL] [Abstract][Full Text] [Related]
22. Robust Identification of Alzheimer's Disease subtypes based on cortical atrophy patterns.
Park JY; Na HK; Kim S; Kim H; Kim HJ; Seo SW; Na DL; Han CE; Seong JK;
Sci Rep; 2017 Mar; 7():43270. PubMed ID: 28276464
[TBL] [Abstract][Full Text] [Related]
23. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression.
van de Beek M; van Steenoven I; van der Zande JJ; Barkhof F; Teunissen CE; van der Flier WM; Lemstra AW
Mov Disord; 2020 May; 35(5):859-867. PubMed ID: 32048343
[TBL] [Abstract][Full Text] [Related]
24. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
25. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
[TBL] [Abstract][Full Text] [Related]
26. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
28. The structural MRI markers and cognitive decline in prodromal Alzheimer's disease: a 2-year longitudinal study.
Wei H; Kong M; Zhang C; Guan L; Ba M;
Quant Imaging Med Surg; 2018 Nov; 8(10):1004-1019. PubMed ID: 30598878
[TBL] [Abstract][Full Text] [Related]
29. Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.
Ossenkoppele R; Lyoo CH; Sudre CH; van Westen D; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Westman E; Tsai R; Kramer J; Boxer AL; Gorno-Tempini ML; La Joie R; Miller BL; Rabinovici GD; Hansson O
Alzheimers Dement; 2020 Feb; 16(2):335-344. PubMed ID: 31672482
[TBL] [Abstract][Full Text] [Related]
30. Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer's disease.
Blanc F; Colloby SJ; Cretin B; de Sousa PL; Demuynck C; O'Brien JT; Martin-Hunyadi C; McKeith I; Philippi N; Taylor JP
Alzheimers Res Ther; 2016 Jul; 8():31. PubMed ID: 27484179
[TBL] [Abstract][Full Text] [Related]
31. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
[TBL] [Abstract][Full Text] [Related]
32. Malignant progression in parietal-dominant atrophy subtype of Alzheimer's disease occurs independent of onset age.
Na HK; Kang DR; Kim S; Seo SW; Heilman KM; Noh Y; Na DL
Neurobiol Aging; 2016 Nov; 47():149-156. PubMed ID: 27592283
[TBL] [Abstract][Full Text] [Related]
33. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
[TBL] [Abstract][Full Text] [Related]
34. Morphometric network differences in ageing versus Alzheimer's disease dementia.
Pichet Binette A; Gonneaud J; Vogel JW; La Joie R; Rosa-Neto P; Collins DL; Poirier J; Breitner JCS; Villeneuve S; Vachon-Presseau E; ;
Brain; 2020 Feb; 143(2):635-649. PubMed ID: 32040564
[TBL] [Abstract][Full Text] [Related]
35. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
36. Network localization of clinical, cognitive, and neuropsychiatric symptoms in Alzheimer's disease.
Tetreault AM; Phan T; Orlando D; Lyu I; Kang H; Landman B; Darby RR;
Brain; 2020 Apr; 143(4):1249-1260. PubMed ID: 32176777
[TBL] [Abstract][Full Text] [Related]
37. Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event-based model of disease progression.
Firth NC; Primativo S; Brotherhood E; Young AL; Yong KXX; Crutch SJ; Alexander DC; Oxtoby NP
Alzheimers Dement; 2020 Jul; 16(7):965-973. PubMed ID: 32489019
[TBL] [Abstract][Full Text] [Related]
38. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
39. Particulate matter and episodic memory decline mediated by early neuroanatomic biomarkers of Alzheimer's disease.
Younan D; Petkus AJ; Widaman KF; Wang X; Casanova R; Espeland MA; Gatz M; Henderson VW; Manson JE; Rapp SR; Sachs BC; Serre ML; Gaussoin SA; Barnard R; Saldana S; Vizuete W; Beavers DP; Salinas JA; Chui HC; Resnick SM; Shumaker SA; Chen JC
Brain; 2020 Jan; 143(1):289-302. PubMed ID: 31746986
[TBL] [Abstract][Full Text] [Related]
40. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
Beheshti I; Demirel H; Matsuda H;
Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
